Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

LIBTAYO 350 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
cemiplimab
Company:  
Regeneron UK Limited See contact details
ATC code: 
L01FF06
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

LIBTAYO 350 mg concentrate for solution for infusion Patient Alert Card

Important safety information to minimise the risks of immune-mediated adverse reactions. This Patient Alert Card will help you identify and report side effects from your treatment with cemiplimab.

{pdf_link}

LIBTAYO 350 mg concentrate for solution for infusion Patient Guide

Important safety information to minimise complications from immune-mediated adverse reactions. This Patient Guide will help you identify and report side effects from your treatment with cemiplimab.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Regeneron UK Limited
Company image
Address
Regeneron UK Limited, The Charter Building, Vine Street, Uxbridge, Middlesex, UB8 1JG, UK
WWW
www.regeneron.co.uk
Telephone
+44 (0)1895 280 790
Medical Information Direct Line
0800 917 7120